In fact, immunohistochemical analysis revealed reduced immunoreactivity for PSA and no immunoreactivity for PSMA in prostate biopsy specimens of BPH patients after phytotherapeutic compound administration. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.